Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis
Background: Inflammatory bowel disease (IBD) occurs in up to 70%–80% of patients with primary sclerosing cholangitis (PSC). Oral vancomycin therapy (OVT) has been reported to be effective in the treatment of IBD associated with PSC (IBD-PSC). Objectives: To examine the effectiveness and safety of OV...
Saved in:
Main Authors: | Wassel Sannaa, Mazen Almasry, Mustafa Peedikayil, Alyssa A. Grimshaw, Mashary Attamimi, Abdulelah AlMutairdi, Badr Al-Bawardy |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/17562848241312766 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful Treatment of Recurrent Primary Sclerosing Cholangitis after Orthotopic Liver Transplantation with Oral Vancomycin
by: Yinka K. Davies, et al.
Published: (2013-01-01) -
Primary sclerosing cholangitis
by: Marina G Silveira, et al.
Published: (2008-01-01) -
Chromoendoscopy in colorectal surveillance for primary sclerosing cholangitis and inflammatory bowel disease
by: Rodrigo V Motta, et al.
Published: (2025-01-01) -
Unusual Presentation of Primary Sclerosing Cholangitis
by: BC Pineau, et al.
Published: (1997-01-01) -
Prognostic Models of Primary Sclerosing Cholangitis
by: A. I. Dolgushina, et al.
Published: (2023-02-01)